Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of INNOPRAZOLE 20 mg vs Nexium 20 mg in Healthy Thai Volunteers (Fasting)
TCTR20251119001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by International Bio Service. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20251119001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251119001.